Effect of contrast injection protocol with dose tailored to patient weight and fixed injection duration on aortic and hepatic enhancement at multidetector-row helical CT.
The aim of this study was to investigate the effect of a contrast material injection protocol with dose and injection rate of contrast material tailored to patient weight (dose tailored to patient weight and fixed injection duration). Hepatic helical CT was performed in 92 patients with chronic liver damage with a dose of 1.4 ml (518 mgI) at a rate of 0.056 ml/s per kilogram body weight of Iopamidol 370. Attenuation values of liver and aorta were measured for calculation of maximum aortic and hepatic enhancement, time to maximum hepatic enhancement, and end of hepatic arterial phase. Correlation coefficients between the injection rate and the four parameters were r=0.008, 0.057, 0.167, and 0.036, and there were no statistically significant correlations between the injection rates and the four parameters. In our injection protocol, uniform temporal scan window may be achieved and the injection rate can be reduced in lighter patients without reducing the degree of enhancement in the aorta and the liver.